Absci Corp. (ABSI)
2.925
-0.04
(-1.18%)
USD |
NASDAQ |
Apr 07, 16:00
2.925
0.00 (0.00%)
After-Hours: 19:42
Absci EPS Diluted (Quarterly) : -0.1963 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Johnson & Johnson | 2.098 |
| Pfizer Inc. | -0.2898 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.56M |
| Revenue (Quarterly) | 0.65M |
| Total Expenses (Quarterly) | 30.21M |
| Enterprise Value | 313.95M |
| Gross Profit Margin (Quarterly) | -335.1% |
| Profit Margin (Quarterly) | -4.55K% |
| Earnings Yield | -29.95% |
| Normalized Earnings Yield | -30.78 |